United StatesWomen and Lung Cancer Research and Preventive Services Act of 2025
What it does
This bill requires the Department of Health and Human Services to conduct an interagency review to accelerate lung cancer research, prevention, and awareness with respect to women and underserved populations.
More detail
The review must
report on the status of existing research and current knowledge gaps;
identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and
provide recommendations for a national lung cancer screening strategy and public education campaign.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Apr 22Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.Latest
- Apr 21Mrs. Harshbarger moved to suspend the rules and pass the bill.
- Apr 21Considered under suspension of the rules. (consideration: CR H3020-3021)
- Apr 21DEBATE - The House proceeded with forty minutes of debate on H.R. 2319.
- Apr 21Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H3020)Passed House
- Apr 21Motion to reconsider laid on the table Agreed to without objection.
- 2025
- Nov 18Reported by the Committee on Energy and Commerce. H. Rept. 119-382.
- Nov 18Placed on the Union Calendar, Calendar No. 332.
- Apr 29Committee Consideration and Mark-up Session Held
- Apr 29Ordered to be Reported by Voice Vote.
- Mar 25Introduced in House
- Mar 25Referred to the House Committee on Energy and Commerce.Introduced